TIME TO MARKET AND PRICE COMPARISON FOR BIOSIMILAR DRUGS IN EU5

被引：0
|
作者：
Lopez, N. [1 ]
Prada, M. [2 ]
Berard, I [3 ]
Schleich, W. [4 ]
Melson, C. [5 ]
机构：
[1] Oblikue Consulting SL, Barcelona, Spain
[2] Intexo, Rome, Italy
[3] NEXTEP, Paris, France
[4] MArS Market Access & Pricing Strategy GmbH, Ansbach, Germany
[5] Decideum Ltd, London, England
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.09.1111
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PHP217
引用
收藏
页码：S186 / S187
页数：3
相关论文
共 50 条
  • [21] DIFFERENCE BETWEEN UNITED STATES AND EU AUTHORISATION TIMELINES AND TIME TO REIMBURSEMENT IN THE EU5
    Sun, D.
    Beckerman, R.
    VALUE IN HEALTH, 2014, 17 (03) : A17 - A17
  • [22] MARKET ACCESS CHALLENGES AND OPPORTUNITIES FOR ANTI-INFECTIVES: AN EU5 PERSPECTIVE
    Samuel, J. J.
    Leung, S. K.
    Maram, V
    Mukku, S. R.
    Ohanjanyan, A.
    VALUE IN HEALTH, 2018, 21 : S158 - S158
  • [23] OPIOID ADDICTION TREATMENT IN THE EU5: MARKET ACCESS LEVERS FOR EMERGING BRANDS ENTERING A GENERIC MARKET
    Taylor, N.
    Cox, J.
    Fletcher-Louis, M.
    Ribeiro, A.
    VALUE IN HEALTH, 2015, 18 (07) : A413 - A413
  • [24] IMPACT OF BIOSMILARS ON THE PRICE AND ACCESS OF ORIGINATORS IN MAJOR AUTOIMMUNE INDICATIONS: AN EU5 PERSPECTIVE
    Edathodu, A.
    Mukku, S. R.
    Smith, L. A.
    Samuel, J. J.
    VALUE IN HEALTH, 2018, 21 : S260 - S260
  • [25] PRICE COMPARISON OF NEW DRUGS IN JAPAN, EU AND US
    Maruyama, M.
    Tsujimura, K.
    Kasahara, M.
    Yamabe, K.
    VALUE IN HEALTH, 2017, 20 (09) : A655 - A656
  • [26] 北汽新能源EU5
    汽车观察, 2018, (11) : 194 - 194
  • [27] MARKET ACCESS TRENDS OF PHARMACEUTICAL PRODUCTS IN THE EU5 AND US (2009-2019)
    Mycka, J. M.
    Dellamano, R.
    Lobb, W.
    Dalal, N.
    Dellamano, L.
    Pereira, E.
    VALUE IN HEALTH, 2021, 24 : S151 - S151
  • [28] MARKET ACCESS FOR COMPANION DIAGNOSTICS IN ONCOLOGY IN THE EU5 AND ASIA-PACIFIC REGION
    Agashe, V. R.
    Arvin-Berod, C.
    Martel, M.
    Sarnes, M.
    VALUE IN HEALTH, 2018, 21 : S272 - S272
  • [29] MARKET ACCESS TRENDS ACROSS THE EU5 AND US: 2009 TO 2018-AN UPDATE
    Mycka, J.
    Lobb, W.
    Dellamano, R.
    Dalal, N.
    Dellamano, L.
    Pereira, E.
    Mora, M.
    Pollere, D.
    Papa, R.
    VALUE IN HEALTH, 2019, 22 : S300 - S300
  • [30] 'Biosimilar' drugs poised to penetrate market
    Heidi Ledford
    Nature, 2010, 468 : 18 - 19
12345